What is Bristol-Myers Squibb's deferred taxes?

Bristol-Myers Squibb (BMY) reported deferred taxes of $161M in Q1 2026.

How has Bristol-Myers Squibb's deferred taxes changed year-over-year?

Bristol-Myers Squibb's deferred taxes decreased by 27.8% year-over-year, from $223M to $161M.

What is the long-term trend for Bristol-Myers Squibb's deferred taxes?

Over 4 years (2021 to 2025), Bristol-Myers Squibb's deferred taxes has grown at a -8.8% compound annual growth rate (CAGR), from -$1.39B to -$965M.

What does deferred taxes mean?

Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.

Bristol-Myers Squibb BMY Deferred Taxes

Deferred Taxes at other companies

PfizerPFE

-$12M+98.2%

Johnson & JohnsonJNJ

$159M-92.7%

Merck & Co.MRK

-$315M-69.4%

IncyteINCY

$63.42M+1,046%

Gilead SciencesGILD

$179M+190%

Neurocrine BiosciencesNBIX

-$61.1M-346%

Other financials

Income statement

See full

Revenue$11.5B+2.6%

Gross profit$8.1B-1.2%

Net income$2.7B+9.0%

EPS (diluted)$1.31+9.2%

Balance sheet

See full

Cash & equivalents$9.6B-12.0%

Total debt$44.7B-10.5%

Total equity$20.1B+15.4%

Total assets$86.5B-6.4%

Cash flow

See full

Operating cash flow$1.1B-43.5%

CapEx$347.0M+33.5%

Free cash flow$757.0M-55.3%

Valuation

See full

Market cap$117.66B+25.0%

Enterprise value$152.75B+16.8%

P/E16.2×-2.7×

P/S2.4×+0.5×

Profitability

See full

Gross margin70.5%0.0pp

Net margin15%+3.8pp

FCF margin24.6%-2.9pp

Returns & leverage

See full

Return on equity38.8%+7.3pp

Debt / equity2.2×-0.6×

Current ratio1.4×+0.1×

Where this comes from

Reported directly by Bristol-Myers Squibb in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The official record: Bristol-Myers Squibb’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bristol-Myers Squibb's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bristol-Myers Squibb's deferred taxes?: Bristol-Myers Squibb (BMY) reported deferred taxes of $161M in Q1 2026.
How has Bristol-Myers Squibb's deferred taxes changed year-over-year?: Bristol-Myers Squibb's deferred taxes decreased by 27.8% year-over-year, from $223M to $161M.
What is the long-term trend for Bristol-Myers Squibb's deferred taxes?: Over 4 years (2021 to 2025), Bristol-Myers Squibb's deferred taxes has grown at a -8.8% compound annual growth rate (CAGR), from -$1.39B to -$965M.
What does deferred taxes mean?: Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.